Why is Indrayani Biotec falling/rising?

As of 26-Jun, Indrayani Biotech Ltd is experiencing a decline in its stock price, currently at 13.89, which reflects a decrease of 0.23 or 1.63%. The stock has fallen after two consecutive days of gains and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 2.73%, and it has significantly underperformed the market with a year-to-date decline of 61.82% compared to a 7.19% increase in the benchmark. The company's financial health is concerning, as it has reported operating losses and a high Debt to EBITDA ratio of 9.25 times, indicating a weak ability to service debt. Additionally, the stock has generated a return of -76.50% over the past year, with profits plummeting by 134.9%, which has contributed to negative sentiment among investors.
In the broader market context, the stock's short-term performance is notably poor when compared to the Sensex, which has gained 2.94% over the past week. The decline in institutional investor participation, with a decrease in their stake by 1.59%, further reflects a lack of confidence in the company's long-term fundamentals. This trend is compounded by the company's negative results over the last four consecutive quarters, which have led to a significant drop in investor interest. Overall, the combination of weak financial performance, declining institutional support, and underperformance against the benchmark has resulted in the stock's current downward trajectory.